Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01508221 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis
A Phase 2 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 31
- Enrollment target
NCT01508221 is a Phase 2 study that has completed, run by University of Cincinnati. The registered enrollment target is 31 participants.
The verdict
NCT01508221, a Phase 2 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the use of Trental and Vitamin E can help reduce the incidence of radiation necrosis (a lesion that usually occurs at the original tumor site) after radiosurgery. These two drugs are commonly used to treat radiation necrosis when it occurs but the hope is that these drugs can be used to prevent radiation necrosis from ever occurring.
Interventions
- DIETARY_SUPPLEMENT Vitamin E
- DRUG Trental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-06 |
| Est. Completion | 2017-02-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01508221
The ClinicalTrials.gov registry entry for NCT01508221 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin E is the first listed.
NCT01508221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01508221 about?
NCT01508221 is a clinical study titled "Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis". The purpose of this study is to determine whether the use of Trental and Vitamin E can help reduce the incidence of radiation necrosis (a lesion that usually occurs at the original tumor site) after radiosurgery. These two drugs are commonly used to treat radiation necrosis when it occurs but the ho...
What is the current status of trial NCT01508221?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2011-06. Estimated completion is 2017-02-01.
What interventions are being tested in trial NCT01508221?
The interventions under investigation include: Vitamin E (DIETARY_SUPPLEMENT), Trental (DRUG).
Who is sponsoring clinical trial NCT01508221?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.